Myoglobin and C5b9 immunohistochemistry studies in heart tissue from sudden unexpected natural death cases

References

• Saukko P, Knight B. Knight’s forensic pathology. 4th ed. Boca Raton: CRC Press; 2016
   Google Scholar
• DiMaio VJ, DiMaio D. Forensic pathology. 2nd ed. Boca Raton (FL): CRC Press; 2001.
   Google Scholar
• Splitz WU Ed. Spitz and fisher’s medicolegal investigation of death: guideline for the application of pathology to crime investigation. 4th. Springfield (III): Charles C. Thomas; 2006.
   Google Scholar
• Zhu BL, Ishikawa T, Michiue T, Li DR, Zhao D, Kamikodai Y, Tsuda K, Okazaki S, Maeda H. Postmortem cardiac troponin T levels in the blood and pericardial fluid. Part 2: analysis for application in the diagnosis of sudden cardiac death with regard to pathology. Leg Med (Tokyo). 2006;8(2):94–101. doi:10.1016/j.legalmed.2005.10.003
   Google Scholar
• Sapouna R, Gourgiotis D, Athanaselis S, Papadodima S, Spiliopoulou C. Diagnostic value of cardiac troponin I in postmortem diagnosis of myocardial infarction. Am J Forensic Med Pathol. 2013;34(2):139–141. doi:10.1097/PAF.0b013e3182880aa1
   PubMed Web of Science ®Google Scholar
• Barberi C, van den Hondel KE. The use of cardiac troponin T (cTnT) in the postmortem diagnosis of acute myocardial infarction and sudden cardiac death: a systematic review. Forensic Sci Int. 2018;292:.27–38. doi:10.1016/j.forsciint.2018.09.002
   PubMed Web of Science ®Google Scholar
• Fujita M, Fujioka Y, Ommura Y. Histopathological diagnosis of early stages of myocardial infarction: applications of the improved hematoxylin basic fuchsin picric acid (HBFP) staining method to human autopsy hearts. Hokkaido Igaku Zasshi. 1985;60:313–320
   Google Scholar
• Thomsen H, Held H. Susceptibility of C5b-9 to postmortem changes. Int J Legal Med. 106;1994:291.
   PubMed Web of Science ®Google Scholar
• Campobasso C, Dell’erba A, Addante A, Zotti F, Marzullo A, Colonna M. Sudden cardiac death and myocardial ischemia indicators - A comparative study of four immunohistochemical markers. Am J Forensic Med Pathol. 2008;29:154–161. doi:10.1097/PAF.0b013e318177eab7
   PubMed Web of Science ®Google Scholar
• Turillazzi E, Di Paolo M, Neri M, Riezzo I, Fineschi V. A theoretical timeline for myocardial infarction: immunohistochemical evaluation and western blot quantification for Interleukin-15 and monocyte chemotactic protein-1 as very early markers. J Transl Med. 2014 Jul 2;12:188. doi:10.1186/1479-5876-12-188
   PubMed Web of Science ®Google Scholar
• Sabatasso S, Moretti M, Mangin P, Fracasso T. Early markers of myocardial ischemia: from the experimental model to forensic pathology cases of sudden cardiac death. Int J Legal Med. 2018;132(1):197–203. doi:10.1007/s00414-017-1605-7
   PubMed Web of Science ®Google Scholar
• Schäfer H, Mathey D, Hugo F, Bhakdi S. Deposition of the terminal C5b-9 complement complex in infarcted areas of human myocardium. J Immunol. 1986;137(6):1945–1949.
   PubMed Web of Science ®Google Scholar
• Ortmann C, Pfeiffer H, Brinkmann B. A comparative study on the immunohistochemical detection of early myocardial damage. Int J Legal Med. 2000;113(4):215–220. doi:10.1007/s004149900094
   PubMed Web of Science ®Google Scholar
• Barranco R, Ventura F. Immunohistochemistry in the detection of early myocardial infarction: systematic review and analysis of limitations because of autolysis and putrefaction [published online ahead of print]. Appl Immunohistochem Mol Morphol. 2018 Aug 8. doi:10.1097/PAI.0000000000000688
   Google Scholar
• Tegla CA, Cudrici C, Patel S, Trippe R 3rd, Rus V, Niculescu F, Rus H. Membrane attack by complement: the assembly and biology of terminal complement complexes. Immunol Res. 2011;51(1):45–60. doi:10.1007/s12026-011-8239-5
   Google Scholar
• Rzepecka-Woźniak E. Diagnostyka immunohistochemiczna wczesnego zawału mieśnia sercowego dla celów pośmiertnego badania sadowo-lekarskiego [Immunohistochemical diagnostic management of early stages of myocardial infarction for the purposes of postmortem medicolegal examinations]. Arch Med Sadowej Kryminol. 2008;58(1):5–16.
   PubMedGoogle Scholar
• Edston E. Evaluation of agonal artifacts in the myocardium using a combination of histological stains and immunohistochemistry. Am J Forensic Med Pathol. 1997;18(2):163–167. doi:10.1097/00000433-199706000-00011
   PubMed Web of Science ®Google Scholar
• Fracasso T, Pfeiffer H, Michaud K, Köhler H, Sauerland C, Schmeling A. Immunohistochemical expression of fibronectin and C5b-9 in the myocardium in cases of carbon monoxide poisoning. Int J Legal Med. 2011;125(3):377–384. doi:10.1007/s00414-010-0512-y
   PubMed Web of Science ®Google Scholar
• Ribeiro-Silva AS, Martin CC, Rossi MA. Is immunohistochemistry a useful tool in the postmortem recognition of myocardial hypoxia in human tissue with no morphological evidence of necrosis? Am J Forensic Med Pathol. 2002;23(1):72–77. doi:10.1097/00000433-200203000-00016
   PubMed Web of Science ®Google Scholar
• Brinkmann B, Sepulchre MA, Fechner G. The application of selected histochemical and immunohistochemical markers and procedures to the diagnosis of early myocardial damage. Int J Legal Med. 1993;106(3):135–141. doi:10.1007/bf01225234
   PubMed Web of Science ®Google Scholar
• Piercecchi-Marti MD, Lepidi H, Leonetti G, Vire O, Cianfarani F, Pellissier JF. Immunostaining by complement C9: a tool for early diagnosis of myocardial infarction and application in forensic medicine. J Forensic Sci. 2001;46(2):328–334.
   PubMed Web of Science ®Google Scholar
• Aljakna A, Fracasso T, Sabatasso S. Molecular tissue changes in early myocardial ischemia: from pathophysiology to the identification of new diagnostic markers. Int J Legal Med. 2018;132(2):425–438. doi:10.1007/s00414-017-1750-z
   PubMed Web of Science ®Google Scholar